LEASE AGREEMENT BASIC LEASE INFORMATIONLease Agreement • September 22nd, 2004 • Conor Medsystems Inc • California
INTERNATIONAL DISTRIBUTION AGREEMENT BETWEEN CONOR MEDSYSTEMS, INC. AND INTERVENTIONAL TECHNOLOGIES PVT., LTD.International Distribution Agreement • September 22nd, 2004 • Conor Medsystems Inc • California
THIS INTERNATIONAL DISTRIBUTION AGREEMENT (the “Agreement”) is made and entered into as of July 1, 2004, by and between CONOR MEDSYSTEMS IRELAND, LTD., an Irish corporation having its offices at 30 Herbert Street, Dublin 2, Ireland (“Conor”), and INTERVENTIONAL TECHNOLOGIES, PVT., LTD., an Indian corporation having its offices in Mumbai, India 201, Steel House, 2nd Floor 24, Mahal Industrial Estate, Mahakali Caves Road, Andheri(E) Mumbai-400 093 (the “Distributor”).
Distribution AgreementDistribution Agreement • September 22nd, 2004 • Conor Medsystems Inc • New York
This document and all the information contained herein are the Confidential Information (as defined herein) of each of BIOTRONIK AG and Conor Medsystems Ireland, Ltd.
COLLABORATIVE LICENSE AND SUPPLY AGREEMENTCollaborative License and Supply Agreement • September 22nd, 2004 • Conor Medsystems Inc • California
THIS COLLABORATIVE LICENSE AND SUPPLY AGREEMENT (“Agreement”) is entered into this 4th day of April, 2003, and shall be effective as of the date of the last signature below (the “Effective Date”) by and between CONOR MEDSYSTEMS, INC. (“Conor”), a Delaware corporation, with offices at 1360 Willow Road, Second Floor, Menlo Park, California 94025 and PHYTOGEN INTERNATIONAL LLC (“Phytogen”), a limited liability company existing under the laws of Wyoming, having its principal office at First Floor, Unit 41, The Business Centre, Stadium Business Park, Ballycoolin, Dublin 11, Ireland.
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • September 22nd, 2004 • Conor Medsystems Inc • California
This Amended and Restated Investor Rights Agreement (this “Agreement”) is made as of July 30, 2004 by and among Conor Medsystems, Inc., a Delaware corporation (the “Company”) and the investors listed on Schedule A attached hereto (each individually referred to as an “Investor” and collectively the “Investors”).
Conor Medsystems, Inc. EMPLOYMENT, CONFIDENTIAL INFORMATION, INVENTION ASSIGNMENT, AND ARBITRATION AGREEMENTEmployment Agreement • September 22nd, 2004 • Conor Medsystems Inc • California
As a condition of my employment with Conor Medsystems, Inc., its subsidiaries, affiliates, successors or assigns (together the “Company”), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by Company, I agree to the following:
CONOR LETTERHEAD]Distribution Agreement • September 22nd, 2004 • Conor Medsystems Inc
Conor Medsystems Ireland, Ltd. (“Conor”) and Biotronik AG (“Biotronik”) are parties to a Distribution Agreement dated May 25, 2004 (the “Agreement”). By this letter agreement (the “Amendment”), effective as of the date of this letter, Conor and Biotronik hereby agree to amend the Agreement as follows:
SECURITY AGREEMENTSecurity Agreement • September 22nd, 2004 • Conor Medsystems Inc • California
This Security Agreement is made as of August 2, 2002, between Conor Medsystems, Inc., a Delaware corporation (the “Pledgee”), and John F. Shanley (the “Pledgor”).
March 4, 2004 VIA HAND DELIVERY Frank Litvack Conor Medsystems, Inc.Employment Agreement • September 22nd, 2004 • Conor Medsystems Inc
As we discussed, this letter (the “Agreement”) sets forth the new terms and conditions of your employment relationship with Conor Medsystems, Inc. (the “Company”). On March 4, 2004, these terms and conditions were approved by the Company’s Board of Directors (“Board”). Except as expressly stated herein, this Agreement supersedes and replaces all previous agreements between you and the Company, including but not limited to your Engagement Letter dated January 1, 2002 and your Contract Extension dated August 7, 2003. As noted below, your current stock option grants are not affected by this Agreement. The terms contained in this Agreement will become effective as of the date that both you and the Company sign this Agreement (the “Effective Date”).
